MARKET

DRUG

DRUG

Bright Minds Biosciences Inc
NASDAQ
70.10
-3.21
-4.38%
After Hours: 70.10 0 0.00% 17:20 03/27 EDT
OPEN
72.03
PREV CLOSE
73.31
HIGH
74.65
LOW
69.41
VOLUME
177.87K
TURNOVER
--
52 WEEK HIGH
123.75
52 WEEK LOW
23.18
MARKET CAP
686.08M
P/E (TTM)
-35.2580
1D
5D
1M
3M
1Y
5Y
1D
'Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans' - Marijuana Moment
Benzinga · 1d ago
Weekly Report: what happened at DRUG last week (0316-0320)?
Weekly Report · 6d ago
Weekly Report: what happened at DRUG last week (0309-0313)?
Weekly Report · 03/16 09:22
Weekly Report: what happened at DRUG last week (0302-0306)?
Weekly Report · 03/09 09:23
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
TipRanks · 03/05 15:15
HC Wainwright & Co. Maintains Buy on Bright Minds Biosciences, Raises Price Target to $145
Benzinga · 03/04 16:04
Bright Minds price target raised to $145 from $115 at H.C. Wainwright
TipRanks · 03/04 13:39
BRIGHT MINDS BIOSCIENCES INC <DRUG.N>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $145 FROM $115
Reuters · 03/04 13:34
More
About DRUG
Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.

Webull offers Bright Minds Biosciences Inc stock information, including NASDAQ: DRUG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRUG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DRUG stock methods without spending real money on the virtual paper trading platform.